Safety and tolerability of the novel inhaled corticosteroid fluticasone furoate in combination with the β2agonist vilanterol administered once daily for 52 weeks in patients ≥12 years old with asthma: a randomised trial-Reference-Cited by-同舟云学术

Safety and tolerability of the novel inhaled corticosteroid fluticasone furoate in combination with the β2agonist vilanterol administered once daily for 52 weeks in patients ≥12 years old with asthma: a randomised trial

Published:2013-02-25 Issue:6 Volume:68 Page:513-520
ISSN:0040-6376
Container-title:Thorax
language:en
Short-container-title:Thorax

Author:

Busse William W,O'Byrne Paul M,Bleecker Eugene R,Lötvall Jan,Woodcock Ashley,Andersen Leslie,Hicks Wesley,Crawford Jodie,Jacques Loretta,Apoux Ludovic,Bateman Eric D

Publisher

BMJ

Subject

Pulmonary and Respiratory Medicine

Reference19 articles.

1. Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention. Updated 2011. http://www.ginasthma.com/Guidelineitem.asp??l1=2&l2=1&intId=1561 (accessed 16 Jul 2012).

2. National Institutes of Health. Guidelines for the Diagnosis and Management of Asthma (EPR-3) 2007. NHLBI, August; 2007. NIH publication no. 08-4051. http://www.nhlbi.nih.gov/guidelines/asthma/index.htm (accessed 16 Jul 2012).

3. Emerging therapeutic options for asthma;Colice;Am J Manag Care,2011

4. Improved adherence with once-daily versus twice-daily dosing of mometasone furoate administered via a dry powder inhaler: a randomized open-label study;Price;BMC Pulm Med,2010

5. Dose effect of once-daily fluticasone furoate in persistent asthma: a randomized trial;Bateman;Resp Med,2012

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Baseline Characteristics and Maintenance Therapy Choice on Symptom Control, Reliever Use, Exacerbation Risk in Moderate–Severe Asthma: A Clinical Modelling and Simulation Study;Advances in Therapy;2024-09-06

2. Differences in the effectiveness of single, dual, and triple inhaled corticosteroid therapy for reducing future risk of severe asthma exacerbation: A systematic review and network meta-analysis;Heliyon;2024-06

3. Real-World Safety and Effectiveness of Fluticasone Furoate/Vilanterol in Patients with Asthma and/or Chronic Obstructive Pulmonary Disease: A Post-Marketing Study in Korea;Drug Safety;2023-08-31

4. Addition of long-acting beta2 agonists or long-acting muscarinic antagonists versus doubling the dose of inhaled corticosteroids (ICS) in adolescents and adults with uncontrolled asthma with medium dose ICS: a systematic review and network meta-analysis;Cochrane Database of Systematic Reviews;2023-08-21

5. Assessing the Effects of Changing Patterns of Inhaled Corticosteroid Dosing and Adherence with Fluticasone Furoate and Budesonide on Asthma Management;Advances in Therapy;2023-07-12